# CNPLE Cram V2 — Parity Batch 37 Clinical Audit

Audit date: 2026-08-08

Scope: `37-neuro-peds-geri-parity.json` — seven new Full-lesson-driven Cram records added to the 395-object audited V2 estate.

## Disposition

**Clinical second pass: PASS.**

These records remain non-runtime authoring assets until private-core identity reconciliation, Full-lesson source anchoring, exact Quick Check validation, shared Cram integrity certification and learner-render verification succeed.

## Records reviewed

1. `cnple-ca-parity-neuro-syncope-neurologic` — Syncope Neurologic Evaluation
2. `cnple-ca-parity-geri-hypoglycemia-risk` — Hypoglycemia Risk in older adults
3. `cnple-ca-parity-newborn-neonatal-hypoglycemia` — Neonatal Hypoglycemia
4. `cnple-ca-parity-neuro-cluster-headache` — Cluster Headache
5. `cnple-ca-parity-neuro-tension-headache` — Tension Type Headache
6. `cnple-ca-parity-peds-headaches` — Pediatric Headaches
7. `cnple-ca-parity-headache-comprehensive-case` — Comprehensive Headache Case Management

## Clinical audit decisions

### Neurologic syncope

PASS. The record explicitly prevents a common over-testing error: brief convulsive movements do not make every syncopal event epilepsy, and routine neuroimaging/EEG is not recommended for typical syncope with a normal neurologic evaluation. It preserves the core syncope ECG/cardiac-risk assessment and sends focal neurologic findings, persistent altered status, severe sudden headache or seizure features into a targeted neurologic pathway.

Canadian anchor: Choosing Wisely Canada / Canadian Neurological Society and Canadian Society of Internal Medicine syncope recommendations; Canadian Cardiovascular Society syncope/driving framework.

### Older-adult hypoglycemia

PASS. The record treats frailty, cognitive impairment, chronic kidney disease, irregular intake, polypharmacy and insulin/secretagogue therapy as hypoglycemia-risk amplifiers. It does not infer safety from A1C alone and prioritizes individualized targets, regimen simplification/de-intensification when appropriate, caregiver feasibility and recurrent-low prevention.

Canadian anchor: Diabetes Canada `Diabetes in Older People` and `Hypoglycemia in Adults` guidance.

### Neonatal hypoglycemia

PASS after threshold review. The record correctly distinguishes the transitional period from persistent hypoglycemia. For at-risk infants during the first 72 hours it uses the Canadian Paediatric Society 2.6 mmol/L intervention framework, treats symptomatic infants urgently, and distinguishes persistent/recurrent hypoglycemia requiring endocrine/metabolic evaluation. It does not promote routine screening of healthy term AGA newborns without risk factors.

Canadian anchor: Canadian Paediatric Society, updated 2025-03-28.

### Cluster headache

PASS. The record teaches the trigeminal-autonomic/restlessness phenotype, differentiates secondary and ocular/vascular emergencies, uses rapid-onset acute therapy appropriate to the short attack duration, and requires ECG-aware verapamil monitoring rather than presenting prophylaxis as a simple refill decision.

Canadian anchor: Canadian Headache Society cluster-headache review/guidance library.

### Tension-type headache

PASS. The record keeps the diagnosis phenotype-based, screens secondary-headache red flags before treatment, quantifies acute-medication days and explicitly addresses medication-overuse headache. It avoids opioid escalation and avoids imaging a stable primary-headache phenotype solely for reassurance.

Canadian anchor: Canadian Headache Society primary-care headache guidance and Choosing Wisely Canada imaging principles.

### Pediatric headaches

PASS. The record reflects pediatric phenotype differences, requires a neurologic examination and targeted imaging only for secondary-headache concern, and aligns acute migraine treatment with the Canadian Paediatric Society 2025 practice point. Opioids are explicitly excluded from routine pediatric migraine management.

Canadian anchor: Canadian Paediatric Society, `Pharmacological management of acute migraine attacks in children and adolescents presenting to the emergency department`, posted 2025-12-12.

### Comprehensive headache case management

PASS. The record is deliberately a clinical-judgment pathway rather than another migraine summary: danger -> phenotype -> patient-specific treatment -> recurrence/medication-overuse prevention. It integrates pregnancy/postpartum, secondary-headache red flags, medication exposure, imaging decisions and longitudinal disability.

Canadian anchor: Canadian Headache Society guideline/guidance library plus Choosing Wisely Canada imaging principles.

## Safety checks

- No US exam identity is used as a clinical authority.
- SI units are used when numeric glucose thresholds are stated.
- No universal imaging rule replaces clinical red-flag assessment.
- No opioid recommendation is introduced for primary headache.
- No fixed driving interval is invented for syncope.
- No universal pediatric/adult dosing shortcut is introduced.
- Dextrose gel is not presented as a substitute for stabilization of a symptomatic/unwell newborn.
- The seven records remain separate identities; no Cram object is authorized to serve multiple distinct Full lessons.

## Remaining publication gates

1. Parse/required-field validation through the pinned core reconciliation loader.
2. Exact/explicit identity mapping to one current canonical `ca-np-cnple` Full lesson.
3. Full-lesson learner-visible source hash and point/Bottom-Line anchor review.
4. Exactly three lesson-related, single-answer, server-gradable Quick Check IDs.
5. Shared Cram integrity certification.
6. Learner-page Full/Cram render and accessibility verification.
7. Merge/deployment only after all gates pass.
